Safety Outcomes
bleeding
BLEEDING
Treatment assignment was not associated with severe or moderate bleeding for either intermediate metabolizers (HR, 0.70 [95% CI, 0.27-1.85]) or poor metabolizers (HR, 1.58 [95% CI, 0.14-18.29]) and did not differ between the 2 groups (